🇺🇸 Rivastigmine patch in United States

32 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Confusional State — 6 reports (18.75%)
  2. Fall — 5 reports (15.62%)
  3. Agitation — 3 reports (9.38%)
  4. Dyskinesia — 3 reports (9.38%)
  5. Mental Status Changes — 3 reports (9.38%)
  6. Tremor — 3 reports (9.38%)
  7. Urinary Tract Infection — 3 reports (9.38%)
  8. Blood Cholinesterase Decreased — 2 reports (6.25%)
  9. Cholinesterase Inhibition — 2 reports (6.25%)
  10. Constipation — 2 reports (6.25%)

Source database →

Other Neurology approved in United States

Frequently asked questions

Is Rivastigmine patch approved in United States?

Rivastigmine patch does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Rivastigmine patch in United States?

Chung-Ang University Hosptial, Chung-Ang University College of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.